Revenue and profit after tax both increased year-over-year, with strong performance in pharmacy and medical services. The group declared a higher dividend and is in the process of selling its Medical division, which has been reclassified as an asset held for sale.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.